ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sunitinib Malate Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-23K3003
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sunitinib Malate Market Insights Forecast to 2028
BUY CHAPTERS

Global Sunitinib Malate Market Research Report 2025

Code: QYRE-Auto-23K3003
Report
January 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
J&K Scientific
Pfizer Sutent
Topcare pharmaceutical Co., Ltd
Nanjing First Pharmaceutical Co., Ltd.
Target Molecule Corp
CSPC
Qilu Pharmaceutical
Hansoh Pharma

Sunitinib Malate Market

The global market for Sunitinib Malate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Sunitinib Malate is the orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation. This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.
North American market for Sunitinib Malate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sunitinib Malate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Sunitinib Malate include Pfizer Sutent, Topcare pharmaceutical Co., Ltd, Nanjing First Pharmaceutical Co., Ltd., J&K Scientific, Target Molecule Corp., CSPC, Qilu Pharmaceutical, Hansoh Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sunitinib Malate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sunitinib Malate.
The Sunitinib Malate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sunitinib Malate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sunitinib Malate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sunitinib Malate Market Report

Report Metric Details
Report Name Sunitinib Malate Market
Segment by Type
  • 12.5mg
  • 37.5mg
  • 50mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer Sutent, Topcare pharmaceutical Co., Ltd, Nanjing First Pharmaceutical Co., Ltd., J&K Scientific, Target Molecule Corp., CSPC, Qilu Pharmaceutical, Hansoh Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sunitinib Malate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sunitinib Malate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Sunitinib Malate Market report?

Ans: The main players in the Sunitinib Malate Market are Pfizer Sutent, Topcare pharmaceutical Co., Ltd, Nanjing First Pharmaceutical Co., Ltd., J&K Scientific, Target Molecule Corp., CSPC, Qilu Pharmaceutical, Hansoh Pharma

What are the Application segmentation covered in the Sunitinib Malate Market report?

Ans: The Applications covered in the Sunitinib Malate Market report are Advanced Kidney Cancer, GIST (Gastrointestinal Stromal Tumor), Pancreatic Neuroendocrine Tumors

What are the Type segmentation covered in the Sunitinib Malate Market report?

Ans: The Types covered in the Sunitinib Malate Market report are 12.5mg, 37.5mg, 50mg

Recommended Reports

Cancer Therapeutics

Inhibitor Drugs

Tumor Markets

1 Sunitinib Malate Market Overview
1.1 Product Definition
1.2 Sunitinib Malate by Type
1.2.1 Global Sunitinib Malate Market Value Comparison by Type (2024 VS 2031)
1.2.2 12.5mg
1.2.3 37.5mg
1.2.4 50mg
1.3 Sunitinib Malate by Application
1.3.1 Global Sunitinib Malate Market Value by Application (2024 VS 2031)
1.3.2 Advanced Kidney Cancer
1.3.3 GIST (Gastrointestinal Stromal Tumor)
1.3.4 Pancreatic Neuroendocrine Tumors
1.4 Global Sunitinib Malate Market Size Estimates and Forecasts
1.4.1 Global Sunitinib Malate Revenue 2020-2031
1.4.2 Global Sunitinib Malate Sales 2020-2031
1.4.3 Global Sunitinib Malate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sunitinib Malate Market Competition by Manufacturers
2.1 Global Sunitinib Malate Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sunitinib Malate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sunitinib Malate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sunitinib Malate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sunitinib Malate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sunitinib Malate, Product Type & Application
2.7 Global Key Manufacturers of Sunitinib Malate, Date of Enter into This Industry
2.8 Global Sunitinib Malate Market Competitive Situation and Trends
2.8.1 Global Sunitinib Malate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sunitinib Malate Players Market Share by Revenue
2.8.3 Global Sunitinib Malate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sunitinib Malate Market Scenario by Region
3.1 Global Sunitinib Malate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sunitinib Malate Sales by Region: 2020-2031
3.2.1 Global Sunitinib Malate Sales by Region: 2020-2025
3.2.2 Global Sunitinib Malate Sales by Region: 2026-2031
3.3 Global Sunitinib Malate Revenue by Region: 2020-2031
3.3.1 Global Sunitinib Malate Revenue by Region: 2020-2025
3.3.2 Global Sunitinib Malate Revenue by Region: 2026-2031
3.4 North America Sunitinib Malate Market Facts & Figures by Country
3.4.1 North America Sunitinib Malate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sunitinib Malate Sales by Country (2020-2031)
3.4.3 North America Sunitinib Malate Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sunitinib Malate Market Facts & Figures by Country
3.5.1 Europe Sunitinib Malate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sunitinib Malate Sales by Country (2020-2031)
3.5.3 Europe Sunitinib Malate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sunitinib Malate Market Facts & Figures by Region
3.6.1 Asia Pacific Sunitinib Malate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sunitinib Malate Sales by Region (2020-2031)
3.6.3 Asia Pacific Sunitinib Malate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sunitinib Malate Market Facts & Figures by Country
3.7.1 Latin America Sunitinib Malate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sunitinib Malate Sales by Country (2020-2031)
3.7.3 Latin America Sunitinib Malate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sunitinib Malate Market Facts & Figures by Country
3.8.1 Middle East and Africa Sunitinib Malate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sunitinib Malate Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sunitinib Malate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sunitinib Malate Sales by Type (2020-2031)
4.1.1 Global Sunitinib Malate Sales by Type (2020-2025)
4.1.2 Global Sunitinib Malate Sales by Type (2026-2031)
4.1.3 Global Sunitinib Malate Sales Market Share by Type (2020-2031)
4.2 Global Sunitinib Malate Revenue by Type (2020-2031)
4.2.1 Global Sunitinib Malate Revenue by Type (2020-2025)
4.2.2 Global Sunitinib Malate Revenue by Type (2026-2031)
4.2.3 Global Sunitinib Malate Revenue Market Share by Type (2020-2031)
4.3 Global Sunitinib Malate Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sunitinib Malate Sales by Application (2020-2031)
5.1.1 Global Sunitinib Malate Sales by Application (2020-2025)
5.1.2 Global Sunitinib Malate Sales by Application (2026-2031)
5.1.3 Global Sunitinib Malate Sales Market Share by Application (2020-2031)
5.2 Global Sunitinib Malate Revenue by Application (2020-2031)
5.2.1 Global Sunitinib Malate Revenue by Application (2020-2025)
5.2.2 Global Sunitinib Malate Revenue by Application (2026-2031)
5.2.3 Global Sunitinib Malate Revenue Market Share by Application (2020-2031)
5.3 Global Sunitinib Malate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Sutent
6.1.1 Pfizer Sutent Company Information
6.1.2 Pfizer Sutent Description and Business Overview
6.1.3 Pfizer Sutent Sunitinib Malate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Sutent Sunitinib Malate Product Portfolio
6.1.5 Pfizer Sutent Recent Developments/Updates
6.2 Topcare pharmaceutical Co., Ltd
6.2.1 Topcare pharmaceutical Co., Ltd Company Information
6.2.2 Topcare pharmaceutical Co., Ltd Description and Business Overview
6.2.3 Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Topcare pharmaceutical Co., Ltd Sunitinib Malate Product Portfolio
6.2.5 Topcare pharmaceutical Co., Ltd Recent Developments/Updates
6.3 Nanjing First Pharmaceutical Co., Ltd.
6.3.1 Nanjing First Pharmaceutical Co., Ltd. Company Information
6.3.2 Nanjing First Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product Portfolio
6.3.5 Nanjing First Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 J&K Scientific
6.4.1 J&K Scientific Company Information
6.4.2 J&K Scientific Description and Business Overview
6.4.3 J&K Scientific Sunitinib Malate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 J&K Scientific Sunitinib Malate Product Portfolio
6.4.5 J&K Scientific Recent Developments/Updates
6.5 Target Molecule Corp.
6.5.1 Target Molecule Corp. Company Information
6.5.2 Target Molecule Corp. Description and Business Overview
6.5.3 Target Molecule Corp. Sunitinib Malate Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Target Molecule Corp. Sunitinib Malate Product Portfolio
6.5.5 Target Molecule Corp. Recent Developments/Updates
6.6 CSPC
6.6.1 CSPC Company Information
6.6.2 CSPC Description and Business Overview
6.6.3 CSPC Sunitinib Malate Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSPC Sunitinib Malate Product Portfolio
6.6.5 CSPC Recent Developments/Updates
6.7 Qilu Pharmaceutical
6.7.1 Qilu Pharmaceutical Company Information
6.7.2 Qilu Pharmaceutical Description and Business Overview
6.7.3 Qilu Pharmaceutical Sunitinib Malate Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Qilu Pharmaceutical Sunitinib Malate Product Portfolio
6.7.5 Qilu Pharmaceutical Recent Developments/Updates
6.8 Hansoh Pharma
6.8.1 Hansoh Pharma Company Information
6.8.2 Hansoh Pharma Description and Business Overview
6.8.3 Hansoh Pharma Sunitinib Malate Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hansoh Pharma Sunitinib Malate Product Portfolio
6.8.5 Hansoh Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sunitinib Malate Industry Chain Analysis
7.2 Sunitinib Malate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sunitinib Malate Production Mode & Process Analysis
7.4 Sunitinib Malate Sales and Marketing
7.4.1 Sunitinib Malate Sales Channels
7.4.2 Sunitinib Malate Distributors
7.5 Sunitinib Malate Customer Analysis
8 Sunitinib Malate Market Dynamics
8.1 Sunitinib Malate Industry Trends
8.2 Sunitinib Malate Market Drivers
8.3 Sunitinib Malate Market Challenges
8.4 Sunitinib Malate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
J&K Scientific
Pfizer Sutent
Topcare pharmaceutical Co., Ltd
Nanjing First Pharmaceutical Co., Ltd.
Target Molecule Corp
CSPC
Qilu Pharmaceutical
Hansoh Pharma
List of Tables
 Table 1. Global Sunitinib Malate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sunitinib Malate Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sunitinib Malate Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sunitinib Malate Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Sunitinib Malate Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sunitinib Malate Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sunitinib Malate Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sunitinib Malate Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sunitinib Malate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sunitinib Malate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sunitinib Malate, Product Type & Application
 Table 12. Global Key Manufacturers of Sunitinib Malate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sunitinib Malate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sunitinib Malate as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sunitinib Malate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sunitinib Malate Sales by Region (2020-2025) & (K Units)
 Table 18. Global Sunitinib Malate Sales Market Share by Region (2020-2025)
 Table 19. Global Sunitinib Malate Sales by Region (2026-2031) & (K Units)
 Table 20. Global Sunitinib Malate Sales Market Share by Region (2026-2031)
 Table 21. Global Sunitinib Malate Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sunitinib Malate Revenue Market Share by Region (2020-2025)
 Table 23. Global Sunitinib Malate Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sunitinib Malate Revenue Market Share by Region (2026-2031)
 Table 25. North America Sunitinib Malate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sunitinib Malate Sales by Country (2020-2025) & (K Units)
 Table 27. North America Sunitinib Malate Sales by Country (2026-2031) & (K Units)
 Table 28. North America Sunitinib Malate Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sunitinib Malate Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sunitinib Malate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sunitinib Malate Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Sunitinib Malate Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Sunitinib Malate Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sunitinib Malate Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sunitinib Malate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sunitinib Malate Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Sunitinib Malate Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Sunitinib Malate Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sunitinib Malate Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sunitinib Malate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sunitinib Malate Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Sunitinib Malate Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Sunitinib Malate Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sunitinib Malate Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sunitinib Malate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sunitinib Malate Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Sunitinib Malate Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Sunitinib Malate Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sunitinib Malate Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sunitinib Malate Sales (K Units) by Type (2020-2025)
 Table 51. Global Sunitinib Malate Sales (K Units) by Type (2026-2031)
 Table 52. Global Sunitinib Malate Sales Market Share by Type (2020-2025)
 Table 53. Global Sunitinib Malate Sales Market Share by Type (2026-2031)
 Table 54. Global Sunitinib Malate Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sunitinib Malate Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sunitinib Malate Revenue Market Share by Type (2020-2025)
 Table 57. Global Sunitinib Malate Revenue Market Share by Type (2026-2031)
 Table 58. Global Sunitinib Malate Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Sunitinib Malate Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Sunitinib Malate Sales (K Units) by Application (2020-2025)
 Table 61. Global Sunitinib Malate Sales (K Units) by Application (2026-2031)
 Table 62. Global Sunitinib Malate Sales Market Share by Application (2020-2025)
 Table 63. Global Sunitinib Malate Sales Market Share by Application (2026-2031)
 Table 64. Global Sunitinib Malate Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sunitinib Malate Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sunitinib Malate Revenue Market Share by Application (2020-2025)
 Table 67. Global Sunitinib Malate Revenue Market Share by Application (2026-2031)
 Table 68. Global Sunitinib Malate Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Sunitinib Malate Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Sutent Company Information
 Table 71. Pfizer Sutent Description and Business Overview
 Table 72. Pfizer Sutent Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Sutent Sunitinib Malate Product
 Table 74. Pfizer Sutent Recent Developments/Updates
 Table 75. Topcare pharmaceutical Co., Ltd Company Information
 Table 76. Topcare pharmaceutical Co., Ltd Description and Business Overview
 Table 77. Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Topcare pharmaceutical Co., Ltd Sunitinib Malate Product
 Table 79. Topcare pharmaceutical Co., Ltd Recent Developments/Updates
 Table 80. Nanjing First Pharmaceutical Co., Ltd. Company Information
 Table 81. Nanjing First Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product
 Table 84. Nanjing First Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. J&K Scientific Company Information
 Table 86. J&K Scientific Description and Business Overview
 Table 87. J&K Scientific Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. J&K Scientific Sunitinib Malate Product
 Table 89. J&K Scientific Recent Developments/Updates
 Table 90. Target Molecule Corp. Company Information
 Table 91. Target Molecule Corp. Description and Business Overview
 Table 92. Target Molecule Corp. Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Target Molecule Corp. Sunitinib Malate Product
 Table 94. Target Molecule Corp. Recent Developments/Updates
 Table 95. CSPC Company Information
 Table 96. CSPC Description and Business Overview
 Table 97. CSPC Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. CSPC Sunitinib Malate Product
 Table 99. CSPC Recent Developments/Updates
 Table 100. Qilu Pharmaceutical Company Information
 Table 101. Qilu Pharmaceutical Description and Business Overview
 Table 102. Qilu Pharmaceutical Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Qilu Pharmaceutical Sunitinib Malate Product
 Table 104. Qilu Pharmaceutical Recent Developments/Updates
 Table 105. Hansoh Pharma Company Information
 Table 106. Hansoh Pharma Description and Business Overview
 Table 107. Hansoh Pharma Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hansoh Pharma Sunitinib Malate Product
 Table 109. Hansoh Pharma Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Sunitinib Malate Distributors List
 Table 113. Sunitinib Malate Customers List
 Table 114. Sunitinib Malate Market Trends
 Table 115. Sunitinib Malate Market Drivers
 Table 116. Sunitinib Malate Market Challenges
 Table 117. Sunitinib Malate Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sunitinib Malate
 Figure 2. Global Sunitinib Malate Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sunitinib Malate Market Share by Type: 2024 & 2031
 Figure 4. 12.5mg Product Picture
 Figure 5. 37.5mg Product Picture
 Figure 6. 50mg Product Picture
 Figure 7. Global Sunitinib Malate Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Sunitinib Malate Market Share by Application: 2024 & 2031
 Figure 9. Advanced Kidney Cancer
 Figure 10. GIST (Gastrointestinal Stromal Tumor)
 Figure 11. Pancreatic Neuroendocrine Tumors
 Figure 12. Global Sunitinib Malate Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Sunitinib Malate Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Sunitinib Malate Sales (2020-2031) & (K Units)
 Figure 15. Global Sunitinib Malate Average Price (US$/Unit) & (2020-2031)
 Figure 16. Sunitinib Malate Report Years Considered
 Figure 17. Sunitinib Malate Sales Share by Manufacturers in 2024
 Figure 18. Global Sunitinib Malate Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Sunitinib Malate Players: Market Share by Revenue in Sunitinib Malate in 2024
 Figure 20. Sunitinib Malate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Sunitinib Malate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Sunitinib Malate Sales Market Share by Country (2020-2031)
 Figure 23. North America Sunitinib Malate Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Sunitinib Malate Sales Market Share by Country (2020-2031)
 Figure 27. Europe Sunitinib Malate Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Sunitinib Malate Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Sunitinib Malate Revenue Market Share by Region (2020-2031)
 Figure 35. China Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Sunitinib Malate Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Sunitinib Malate Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Sunitinib Malate Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Sunitinib Malate Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Sunitinib Malate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Sunitinib Malate by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Sunitinib Malate by Type (2020-2031)
 Figure 57. Global Sunitinib Malate Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Sunitinib Malate by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Sunitinib Malate by Application (2020-2031)
 Figure 60. Global Sunitinib Malate Price (US$/Unit) by Application (2020-2031)
 Figure 61. Sunitinib Malate Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Sunitinib API Market Research Report 2025
Global Trametinib Market Research Report 2025
Global Fostamatinib Market Research Report 2024
Global Neratinib Market Research Report 2024
Global Osimertinib Market Research Report 2024
Global Satralizumab Market Research Report 2025
Global Oclacitinib Maleate Market Research Report 2024
Global Ceritinib Market Research Report 2024
Global Crizotinib Market Research Report 2024
Global Dicreatine Malate Market Research Report 2024
Global Axitinib Market Research Report 2025
Global Daratumumab Market Research Report 2024
Fostamatinib Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nintedanib Market Research Report 2024
Global Nintedanib API Market Research Report 2025
Global L Citrulline DL Malate Market Research Report 2025
Global Anlotinib Market Research Report 2024
Global Tucatinib Market Research Report 2025
Global Zinc Malate Market Research Report 2024
Global Clebopride Malate Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions